AUGUST 4, 2023

Shorter Treatment for Resistant TB, BPal Succeeds in Boston

By IDSE News Staff

Tuberculosis (TB) disproportionately affects vulnerable populations, including those with limited financial resources, HIV patients, those whose diet is deficient in nutrients, and others. Multidrug-resistant TB (MDR TB) requires regimens lasting 15 to 20 months that are associated with significant side effects and poor outcomes.

Recently, new six-month regimens have been shown to have better results than the long-term treatments, with improved quality of life and health